Zewei Wang

75PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer cell biologyCancer geneticsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (75)

|Oct 08, 2026
Biological Redefinition of Oligometastatic Gastric Cancer Refines Surgical Risk Stratification.

|Jul 11, 2026
TP53 mutation-biased CD8+ T cell exhaustion drives lethal outcome and therapy resistance in urothelial carcinoma.

|Jun 29, 2026
Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinoma.

|Jun 05, 2026
FN1+ macrophages fuel aggressive sarcomatoid differentiation and immunotherapy refractory outcome in clear cell renal cell carcinoma.

|May 20, 2026
Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinoma.

|May 15, 2026
Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpression.

Pageof 13

Frequent Collaborators

13 joint publications

Ruochen Li

12 joint publications

Kaifeng Jin

11 joint publications

Jieti Wang

11 joint publications

Zhaopei Liu